Trial Profile
Phase II trial of Excellair in patients with asthma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2010
Price :
$35
*
At a glance
- Drugs Syk kinase silencer (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 30 Nov 2010 New trial record